UNSPSC 85632348: Supplement right breast with nonautologous tissue substitute, via natural or artificial opening

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right breast with nonautologous tissue substitute, via natural or artificial opening. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0HUT7KZ

UNSPSC 85632348 "Supplement right breast with nonautologous tissue substitute, via natural or artificial opening" is a Commodity code that shows no meaningful recent activity aligned with its stated scope. The code describes a specific surgical procedure involving breast reconstruction, yet the recent state and local opportunities tagged under this code cover independent medical evaluations, occupational health surveillance, pharmacy benefit management, health professional staffing, and surgical benefit carve-out programs — none of which involve breast implantation or tissue substitution. This mismatch indicates either a systematic miscoding of opportunities in the source data or that state and local procurement offices are not actively soliciting this particular surgical service through standardized notice channels.

The six opportunities posted between July and September 2026 span Arizona, California, Washington, Texas, and Florida, issued by city retirement offices, county health systems, state transportation departments, and county probation departments. The City of Phoenix Retirement Office RFP for independent medical evaluation services (RTMRFP26001, due October 16, 2026) and the Washington State Department of Transportation RFP for occupational medical surveillance (RFP20260825, due October 9, 2026) represent the closest activity to health services procurement, but neither involves surgical procedures or implants. Absent evidence that state and local jurisdictions are actively procuring breast reconstruction with nonautologous tissue through this code channel, the code presents limited pursuit opportunity for vendors specializing in surgical implants or reconstructive-surgery services.